Early immune response against retrovirally transduced herpes simplex virus thymidine kinase-expressing gene-modified T cells coinfused with a T cell-depleted marrow graft: An altered immune response?

Human Gene Therapy

Volumn 19, Issue 9, 2008, Pages 937-950

  Mercier Letondal, Patricia ^a,b,c   Deschamps, Marina ^a,b,c   Sauce, Delphine ^a,b   Certoux, Jean Marie ^a,b,c   Milpied, Noël ^d   Lioure, Bruno ^e   Cahn, Jean Yves ^f   Deconinck, Eric ^a,g   Ferrand, Christophe ^a,b,c   Tiberghien, Pierre ^a,b,c   Robinet, Eric ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^c ETABLISSEMENT FRANÇAIS DU SANG   (France)

^d BORDEAUX UNIVERSITY HOSPITAL   (France)

^e UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^f GRENOBLE UNIVERSITY HOSPITAL   (France)

^g UNIVERSITY HOSPITAL OF BESANÇON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT; RETROVIRUS VECTOR; STEROID; THYMIDINE KINASE;

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; DNA MODIFICATION; ENZYME LINKED IMMUNOSPOT ASSAY; EX VIVO STUDY; GRAFT VERSUS HOST REACTION; HERPES SIMPLEX VIRUS; HISTOCOMPATIBILITY; HUMAN; IMMUNE RESPONSE; LYMPHOCYTE TRANSFER; LYMPHOCYTOTOXICITY; PROPHYLAXIS; RETROVIRUS; SIBLING; T LYMPHOCYTE;

ADULT; AMINO ACID SEQUENCE; BONE MARROW TRANSPLANTATION; CYTOMEGALOVIRUS; CYTOTOXICITY, IMMUNOLOGIC; GENETIC VECTORS; GRAFT VS HOST DISEASE; HERPESVIRUS 4, HUMAN; HUMANS; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; MIDDLE AGED; NEOMYCIN; RETROVIRIDAE; SIMPLEXVIRUS; T-LYMPHOCYTES; THYMIDINE KINASE; TRANSDUCTION, GENETIC; TRANSPLANTATION, HOMOLOGOUS; VIRAL PROTEINS;

HERPES; SIMPLEXVIRUS;

EID: 51849145605     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2007.156     Document Type: Article

References (38)

1. Asemissen, A.M., Nagorsen, D., Keilholz, U., Letsch, A., Schmittel, A., Thiel, E., and Scheibenbogen, C. (2001). Flow cytometric determination of intracellular or secreted IFNγ for the quantification of antigen reactive T cells. J. Immunol. Methods 251, 101-108.
2. + T cell responses against viral and tumor antigens using T cells as novel target APC. J. Immunol. Methods 278, 57-66.
3. Berger, C., Flowers, M.E., Warren, E.H., and Riddell, S.R. (2006). Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK-modified donor T cells after allogeneic hematopoietic cell transplantation. Blood 107, 2294-2302.
4. + T-cell loss and impairs secondary antitumor responses after successful initial immunotherapy. Nat. Med. 13, 354-360.
5. Bondanza, A., Valtolina, V., Magnani, Z., Ponzoni, M., Fleischhauer, K., Bonyhadi, M., Traversari, C., Sanvito, F., Toma, S., Radrizzani, M., La Seta-Catamancio, S., Ciceri, F., Bordignon, C., and Bonini, C. (2006). Suicide gene therapy of graft-versus-host disease induced by central memory human T lymphocytes. Blood 107, 1828-1836.
6. Bonini, C., Ferrari, G., Verzeletti, S., Servida, P., Zappone, E., Ruggieri, L., Ponzoni, M., Rossini, S., Mavilio, F., Traversari, C., and Bordignon, C. (1997). HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science 276, 1719-1724.
7. Burt, R.K., Drobyski, W.R., Seregina, T., Traynor, A., Oyama, Y., Keever-Taylor, C., Stefka, J., Kuzel, T.M., Brush, M., Rodriquez, J., Burns, W., Tennant, L., and Link, C. (2003). Herpes simplex thymidine kinase gene-transduced donor lymphocyte infusions. Exp. Hematol. 31, 903-910.
8. Ciceri, F., Bonini, C., Marktel, S., Zappone, E., Servida, P., Bernardi, M., Pescarollo, A., Bondanza, A., Peccatori, J., Rossini, S., Magnani, Z., Salomoni, M., Benati, C., Ponzoni, M., Callegaro, L., Corradini, P., Bregni, M., Traversari, C., and Bordignon, C. (2007). Anti-tumor effects of HSV-TK engineered donor lymphocytes after allogeneic stem cell transplantation. Blood 109, 4698-4707.
9. Coito, S., Sauce, D., Duperrier, A., Certoux, J.M., Bonyhadi, M., Collette, A., Kuehlcke, K., Hervé, P., Tiberghien, P., Robinet, E., and Ferrand, C. (2004). Retrovirus-mediated gene transfer in human primary T lymphocytes induces an activation- and transduction/selection-dependent TCR-B variable chain repertoire skewing of gene-modified cells. Stem Cells Dev. 13, 71-81.
10. Davison, G.M., Novitzky, N., Kline, A., Thomas, V., Abrahams, L., Hale, G., and Waldmann, H. (2000). Immune reconstitution after allogeneic bone marrow transplantation depleted of T cells. Transplantation 69, 1341-1347.
11. Deschamps, M., Mercier, P., Certoux, J.M., Henry, C., Lioure, B., Pagneux, C., Cahn, J.Y., Deconinck, E., Tiberghien, P., Robinet, E., and Ferrand, C. (2007). Deletions within the HSV-tk transgene in long-lasting circulating gene-modified T-cells infused with a hematopoietic graft. Blood 110, 3842-3852.
12. +-enriched blood stem cells. Blood 104, 3408-3409.
13. Fischer, K., and Mackensen, A. (2003). The flow cytometric PKH-26 assay for the determination of T-cell mediated cytotoxic activity. Methods 31, 135-142.
14. Fischer, K., Andreesen, R., and Mackensen, A. (2002). An improved flow cytometric assay for the determination of cytotoxic T lymphocyte activity. J. Immunol. Methods 259, 159-169.
15. Godoy-Ramirez, K., Makitalo, B., Thorstensson, R., Sandstrom, E., Biberfeld, G., and Gaines, H. (2005). A novel assay for assessment of HIV-specific cytotoxicity by multiparameter flow cytometry. Cytometry A 68, 71-80.
16. + T lymphocytes. Nature 421, 852-856.
17. Karlsson, A.C., Martin, J.N., Younger, S.R., Bredt, B.M., Epling, L., Ronquillo, R., Varma, A., Deeks, S.G., McCune, J.M., Nixon, D.F., and Sinclair, E. (2003). Comparison of the ELISPOT and cytokine flow cytometry assays for the enumeration of antigen-specific T cells. J. Immunol. Methods 283, 141-153.
18. Keever, C.A., Small, T.N., Flomenberg, N., Heller, G., Pekle, K., Black, P., Pecora, A., Gillio, A., Kernan, N.A., and O'Reilly, R.J. (1989). Immune reconstitution following bone marrow transplantation: Comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts. Blood 73, 1340-1350.
19. Liberatore, C., Capanni, M., Albi, N., Volpi, I., Urbani, E., Ruggeri, L., Mencarelli, A., Grignani, F., and Velardi, A. (1999). Natural killer cell-mediated lysis of autologous cells modified by gene therapy. J. Exp. Med. 189, 1855-1862.
20. + cytotoxic T-cell responses during chronic viral infection. J. Virol. 68, 8056-8063.
21. Mavilio, F., Ferrari, G., Rossini, S., Nobili, N., Bonini, C., Casorati, G., Traversari, C., and Bordignon, C. (1994). Peripheral blood lymphocytes as target cells of retroviral vector-mediated gene transfer. Blood 83, 1988-1997.
22. + T cells for adoptive T cell therapy using gene-modified activated T cells as antigen presenting cells. J. Immunother. 29, 436-443; discussion 365-436.
23. Riddell, S.R., Elliott, M., Lewinsohn, D.A., Gilbert, M.J., Wilson, L., Manley, S.A., Lupton, S.D., Overell, R.W., Reynolds, T.C., Corey, L., and Greenberg, P.D. (1996). T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nat. Med. 2, 216-223.
24. Robinet, E., Certoux, J.M., Ferrand, C., Maples, P., Hardwick, A., Cahn, J.Y., Reynolds, C.W., Jacob, W., Hervé, P., and Tiberghien, P. (1998). A closed culture system for the ex vivo transduction and expansion of human T lymphocytes. J. Hematother. 7, 205-215.
25. Sauce, D., Bodinier, M., Garin, M., Petracca, B., Tonnelier, N., Duperrier, A., Melo, J.V., Apperley, J.F., Ferrand, C., Hervé, P., Lang, F., Tiberghien, P., and Robinet, E. (2002a). Retrovirus-mediated gene transfer in primary T lymphocytes impairs their anti-Epstein-Barr virus potential through both culture-dependent and selection process-dependent mechanisms. Blood 99, 1165-1173.
26. Sauce, D., Tonnelier, N., Duperrier, A., Petracca, B., De Carvalho Bittencourt, M., Saadi, M., Saas, P., Ferrand, C., Hervé, P., Tiberghien, P., and Robinet, E. (2002b). Influence of ex vivo expansion and retrovirus-mediated gene transfer on primary T lymphocyte phenotype and functions. J. Hematother. Stem Cell Res. 11, 929-940.
27. 51Cr-release assay for monitoring cell-mediated cytotoxicity. J. Transl. Med. 1, 14.
28. Shedlock, D.J., and Shen, H. (2003). Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 300, 337-339.
29. Sun, J.C., and Bevan, M.J. (2003). Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 300, 339-342.
30. + T cells after acute infection. Nat. Immunol. 5, 927-933.
31. + T cells specific for EBV in healthy virus carriers. J. Immunol. 162, 1827-1835.
32. Tassignon, J., Burny, W., Dahmani, S., Zhou, L., Stordeur, P., Byl, B., and de Groote, D. (2005). Monitoring of cellular responses after vaccination against tetanus toxoid: Comparison of the measurement of IFN-γ production by ELISA, ELISPOT, flow cytometry and real-time PCR. J. Immunol. Methods 305, 188-198.
33. Tiberghien, P., Reynolds, C.W., Keller, J., Spence, S., Deschaseaux, M., Certoux, J.M., Contassot, E., Murphy, W.J., Lyons, R., Chiang, Y., Hervé, P., Longo, D.L., and Ruscetti, F.W. (1994). Ganciclovir treatment of herpes simplex thymidine kinase-transduced primary T lymphocytes: An approach for specific in vivo donor T-cell depletion after bone marrow transplantation? Blood 84, 1333-1341.
34. Tiberghien, P., Cahn, J.Y., Brion, A., Deconinck, E., Racadot, E., Hervé, P., Milpied, N., Lioure, B., Gluckman, E., Bordigoni, P., Jacob, W., Chiang, Y., Marcus, S., Reynolds, C., and Longo, D. (1997). Use of donor T-lymphocytes expressing herpes-simplex thymidine kinase in allogeneic bone marrow transplantation: A phase I-II study. Hum. Gene Ther. 8, 615-624.
35. Tiberghien, P., Ferrand, C., Lioure, B., Milpied, N., Angonin, R., Deconinck, E., Certoux, J.M., Robinet, E., Saas, P., Petracca, B., Juttner, C., Reynolds, C.W., Longo, D.L., Hervé, P., and Cahn, J.Y. (2001). Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft. Blood 97, 63-72.
36. Traversari, C., Marktel, S., Magnani, Z., Mangia, P., Russo, V., Ciceri, F., Bonini, C., and Bordignon, C. (2007). The potential immunogenicity of the TK suicide gene does not prevent full clinical benefit associated with the use of TK-transduced donor lymphocytes in HSCT for hematologic malignancies. Blood 109, 4708-4715.
37. Verzeletti, S., Bonini, C., Marktel, S., Nobili, N., Ciceri, F., Traversari, C., and Bordignon, C. (1998). Herpes simplex virus thymidine kinase gene transfer for controlled graft-versus-host disease and graft-versus- leukemia: Clinical follow-up and improved new vectors. Hum. Gene Ther. 9, 2243-2251.
38. Wells, A.D., Gudmundsdottir, H., and Turka, L.A. (1997). Following the fate of individual T cells throughout activation and clonal expansion: Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response. J. Clin. Invest. 100, 3173-3183.